Data as of Mar 14
| +0.15 / +0.58%|
The 3 analysts offering 12-month price forecasts for Natus Medical Inc have a median target of 29.00, with a high estimate of 29.00 and a low estimate of 25.00. The median estimate represents a +11.20% increase from the last price of 26.08.
The current consensus among 5 polled investment analysts is to Hold stock in Natus Medical Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.